TerrAscend Q1 2026: revenue $65.5M, adj EBITDA $17.4M, 15th consecutive positive cash flow

TerrAscend Corp.

2026-Q1 EPS reported -$0.03 revenue$65,539,000

Net revenue $65.5M, +1.9% YoY; gross margin 52.8% vs 53.9% a year ago.
GAAP net loss from cont ops $6.8M vs $7.7M YoY; Adj EBITDA $17.4M (26.5% margin).
Net cash from cont ops $8.7M; free cash flow $7.8M; 15th straight quarter positive ops cash flow.
U.S. medical cannabis rescheduled to Schedule III post-quarter, eliminating 280E tax on medical cannabis.
Appointed Eric Jackson as CFO effective April 2026; executed NCIB repurchases of 115k shares at ~$0.66.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

TerrAscend Corp. reported first quarter ended March 31, 2026 results: revenue $65.5 million, net income ($6.8 million).

Period: first quarter ended March 31, 2026
Revenue: $65.5 million
Net income: ($6.8 million)
Result: reported results

Exact text from the filing

Net Revenue of $65.5 million, compared to $64.3 million in the first quarter of 2025 • Gross Profit Margin of 52.8% • GAAP Net Loss from continuing operations was $6.8 million • EBITDA from continuing operations1 was $17.3 million • Adjusted EBITDA from continuing operations1 was $17.4 million or 26.5% of net revenue • Net Cash provided from continuing operations was $8.7 million • Free Cash Flow1 was $7.8 million

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

TerrAscend Corp. filing history →

Source: SEC EDGAR

accession 0001193125-26-210379

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.